Address: |
4989 Golden Foothill Pkwy., Suite 2 |
Education: |
|
Licenses: |
|
Employment: |
|
Clinical Trial Participation: |
START-CKD: Strategies Using Darbepoetin alpha to Avoid Transfusion in Chronic Kidney Disease Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects with Chronic Kidney Disease on Hemodialysis A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects with Stage III to V Chronic Kidney Disease Not on Dialysis A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects with Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia A Randomized, Double-blind, parallel-group, multi-center study to evaluate the efficacy and safety of XXX epoetin alfa vs. US licensed eopetin alfa in the treatment of anemia associated with Chronic Kidney Disease: SANDOZ |
Capital Nephrology Medical Group
333 University Av., Suite 120
Sacramento, CA 95825
Tel: 916-929-8564
Fax: 916-929-4529
View Office Locations in a larger map